In Pepscan’s cleanroom, peptides are tailored to our customer’s needs and specifications. Through streamlined project management and strict GMP-compliant procedures, rapid and high-quality clinical peptide manufacturing is ensured. Dennis Lub is one of the members of Pepscan’s cleanroom team. “Together with the other team members, we make sure that all manufacturing steps performed in the cleanroom, like purification with dedicated columns, freeze drying, and aliquoting, comply with our procedures, meet our quality standards, and are documented in batch records with …

Our unique, small-scale, and lean pharmaceutical-standard processes give us agility. An important reason why Pepscan has become the preferred supplier of peptide products and related services for an increasing number of companies. Recently, a new PGS15 safety storage for our chemicals was installed next to our existing facility. This new storage brings many advantages: expands our storage capacity increases quality storage conditions, as the new storage is fully temperature controlled enable synthesis lab expansion by freeing up space reduces risk …

Quality is at the core of our organization. We have a quality management system (QMS) in place, which verifies that the clinical phase and R&D products and services we supply meet or exceed industry standards. We are pleased to announce that we had a successful ISO 9001:2015 audit and received our renewed ISO-certificate. “Certification by a third-party body has once again confirmed that we meet the requirements of the internationally recognized ISO 9001 standard,” says Hanne Kho, QA responsible at …

Lelystad, the Netherlands – November 20th 2020 – Pepscan, the all-in-one peptide service provider with proprietary peptide constraining technologies, today announced that it has entered into a global agreement with Bicycle Therapeutics plc regarding the use of Pepscan’s CLIPS peptide technology for the further development of Bicycle’s product candidates BT1718 and THR-149. As expert in constrained peptides, Pepscan developed a proprietary, highly versatile constraining technology to lock peptides into active conformations, called CLIPS (Chemical Linkage of Peptides onto Scaffolds). The …

“The therapeutic peptide pipeline under one roof” Pepscan’s team of around 40 entrepreneurial, specialized scientists focus their daily work on enabling breakthroughs in life sciences. Eline Fijlstra joined Pepscan in 2017 as one of the technicians in the epitope mapping group. She is now a technician and analyst in the peptide discovery group. “After finishing my Bachelor’s in Biology and Medical Laboratory Research at HAN University of Applied Sciences, I found at Pepscan’s planned peptide discovery group the perfect place …

In addition to a team of highly skilled specialists in smart peptide science, our flexible manufacturing capabilities are key to how we support our customers. Flexibility not only allows us to reliably deliver personalized peptides for neoantigen vaccines in very short timelines, but it also gives us the ability to quickly ramp up or make room for additional clinical or R&D orders in our synthesis pipeline. Lean Six Sigma Yellow Belt As part of Pepscan’s training program, a group of …

Pepscan lance aujourd’hui la version française de son site internet et salue chaleureusement tous ses visiteurs francophones. Nous répondons ainsi à la demande croissante des visiteurs francophones sur notre site internet et nous présentons désormais de façon accessible notre expertise en matière de peptides, nos produits complexes et notre technologie. Notre site internet nous permet également de partager des informations sur les bénéfices que leur exploitation apporte à la communauté scientifique. « Alors que la science des peptides est majoritairement anglophone, …

To accommodate the growing numbers of French speakers visiting our website, Pepscan has launched a French version. Our website not only serves to inform visitors about Pepscan’s offering, but also is a tool for sharing knowledge around our technologies and the benefits they bring to the scientific community. “Although peptide science – and as a result Pepscan – is a highly international and English-focused field, we want to welcome French speaking scientists in their own language. This approach fits with …

“I’m convinced that collaboration and sharing knowledge are key in supporting our clients to be successful in the clinics.” The market for personalized neoantigen peptide cancer vaccines is very young. Currently there are about 20-30 clinical trials running worldwide and one of the first Phase I trials finished recently. Results for this new approach of cancer treatment are very promising and more studies are started up at a quick rate. Pepscan, as the manufacturer of neoantigen peptides and working with …

Recently, we launched a worldwide campaign to stress the importance of epitope mapping in therapeutic antibody development. Part of this campaign is a movie featuring Dr. Dennis Flierman (Director Epitope Mapping) and Dr. Marty Wulferink (European and Dutch patent attorney). Epitope mapping not only plays a key role in functional understanding and selection of antibodies, but also in IP protection and FDA/EMA approval. Recent patent disputes have illustrated the necessity of epitope mapping in protecting a company’s interests. It is …